stockrowCogent Biosciences, Inc. (COGT) vs PTC Therapeutics, Inc. (PTCT)
- Cogent Biosciences, Inc. COGT 31.60 +6.83%
- PTC Therapeutics, Inc. PTCT 65.55 −0.18%
Cogent Biosciences, Inc. and PTC Therapeutics, Inc. are both Biotechnology companies. Cogent Biosciences, Inc. and PTC Therapeutics, Inc. are of similar size ($5.5B and $5.1B). Cogent Biosciences, Inc. grew revenue faster over the last twelve months: 110.2% against −35.1%. Cogent Biosciences, Inc. has the higher net margin (0.00% vs −9.17%) and the lower return on invested capital (0.00% vs 17.7%). Across the 17 metrics below, PTC Therapeutics, Inc. leads on 13 and Cogent Biosciences, Inc. on 4.
Valuation
Profitability
| Metric | COGT | PTCT | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 93.20% | 65.16% |
| Operating margin | 0.00% | 12.78% | 0.00% |
| Net margin | 0.00% | (9.17%) | 0.00% |
| Free cash flow margin | 0.00% | (22.43%) | 0.00% |
| Return on equity | (146.55%) | 61.08% | (50.12%) |
| Return on assets | (68.00%) | (3.62%) | (45.60%) |
| Return on invested capital | 0.00% | 17.66% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack